Royal Bank of Canada
GILD icon

Royal Bank of Canada’s Gilead Sciences GILD Stock Holding History

Royal Bank of Canada’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,000
Closed -$2.15M – 7204
2022
Q4 		$2.15M Buy
25,000
+24,100
+2,678% +$1.91M ﹤0.01% 2840
2022
Q3 		$56K Hold
900
– – ﹤0.01% 5672
2022
Q2 		$56K Sell
900
-120,000
-99% -$7.43M ﹤0.01% 5663
2022
Q1 		$7.19M Sell
120,900
-146,700
-55% -$9.38M ﹤0.01% 1970
2021
Q4 		$19.4M Sell
267,600
-120,000
-31% -$8.27M ﹤0.01% 1415
2021
Q3 		$27.1M Buy
387,600
+142,600
+58% +$10M 0.01% 1128
2021
Q2 		$16.9M Sell
245,000
-200,200
-45% -$13.4M ﹤0.01% 1468
2021
Q1 		$28.8M Buy
445,200
+230,200
+107% +$14.8M 0.01% 1040
2020
Q4 		$12.5M Buy
215,000
+45,500
+27% +$2.75M ﹤0.01% 1552
2020
Q3 		$10.7M Sell
169,500
-500
-0.3% -$34.7K ﹤0.01% 1489
2020
Q2 		$13.1M Sell
170,000
-95,000
-36% -$7.28M 0.01% 1285
2020
Q1 		$19.8M Sell
265,000
-79,000
-23% -$5.46M 0.01% 905
2019
Q4 		$22.4M Buy
344,000
+49,000
+17% +$3.19M 0.01% 1092
2019
Q3 		$18.7M Buy
295,000
+113,400
+62% +$7.41M 0.01% 1123
2019
Q2 		$12.3M Sell
181,600
-100
-0.1% -$6.58K ﹤0.01% 1421
2019
Q1 		$11.8M Sell
181,700
-171,900
-49% -$11.4M 0.01% 1407
2018
Q4 		$22.1M Buy
353,600
+60,900
+21% +$4.26M 0.01% 933
2018
Q3 		$22.6M Sell
292,700
-35,700
-11% -$2.7M 0.01% 1049
2018
Q2 		$23.3M Buy
328,400
+36,300
+12% +$2.56M 0.01% 983
2018
Q1 		$22M Sell
292,100
-417,700
-59% -$33.2M 0.01% 1027
2017
Q4 		$50.9M Buy
709,800
+411,300
+138% +$31.2M 0.02% 594
2017
Q3 		$24.2M Buy
298,500
+58,700
+24% +$4.49M 0.01% 978
2017
Q2 		$17M Sell
239,800
-21,400
-8% -$1.42M 0.01% 1160
2017
Q1 		$17.7M Sell
261,200
-306,300
-54% -$21.5M 0.01% 1107
2016
Q4 		$40.6M Sell
567,500
-508,900
-47% -$37.8M 0.02% 625
2016
Q3 		$85.2M Buy
1,076,400
+632,400
+142% +$51.4M 0.05% 319
2016
Q2 		$37M Buy
444,000
+148,300
+50% +$13.2M 0.02% 592
2016
Q1 		$27.2M Sell
295,700
-211,000
-42% -$19M 0.02% 743
2015
Q4 		$51.3M Sell
506,700
-60,700
-11% -$6.32M 0.03% 440
2015
Q3 		$55.7M Sell
567,400
-769,300
-58% -$85.4M 0.04% 325
2015
Q2 		$157M Sell
1,336,700
-257,900
-16% -$28.2M 0.11% 142
2015
Q1 		$156M Buy
1,594,600
+748,900
+89% +$76M 0.11% 143
2014
Q4 		$79.7M Buy
845,700
+232,700
+38% +$24.1M 0.05% 279
2014
Q3 		$65.3M Buy
613,000
+90,000
+17% +$8.81M 0.04% 299
2014
Q2 		$43.4M Hold
523,000
– – 0.03% 421
2014
Q1 		$37.1M Sell
523,000
-2,296,200
-81% -$180M 0.03% 451
2013
Q4 		$212M Buy
2,819,200
+60,500
+2% +$4.21M 0.15% 105
2013
Q3 		$173M Buy
2,758,700
+481,000
+21% +$28.7M 0.13% 108
2013
Q2 		$117M Buy
+2,277,700
New +$119M 0.1% 136

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Royal Bank of Canada's GILD Position: Q1 2026 in Review

Royal Bank of Canada reduced its Gilead Sciences (GILD) stake by 4.5% in Q1 2026, selling an estimated $37.2M and leaving 5,647,122 shares worth $787M. The position accounts for 0.14% of the portfolio, ranked #142.

Royal Bank of Canada first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $973M in Q4 2022. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Royal Bank of Canada held 5,647,122 shares of Gilead Sciences worth $787M as of Q1 2026.
  • Royal Bank of Canada sold 265,759 Gilead Sciences shares in Q1 2026, an estimated $37.2M.
  • Gilead Sciences made up 0.14% of Royal Bank of Canada's portfolio in Q1 2026, its #142 holding.
  • Royal Bank of Canada first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Gilead Sciences position peaked at $973M in Q4 2022.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.